Table 3.
Results of multivariate regression analysis * for post-operative outcomes.
| Variables | APRI (>0.5 vs. ≤0.5) | MELD | ALBI | |||
|---|---|---|---|---|---|---|
| OR/HR (95% CI) | P | OR/HR (95% CI) | P | OR/HR (95% CI) | P | |
| In-hospital death | 23.73 (8.89–63.33) | <0.001 | 1.08 (1.03–1.14) | 0.003 | 4.45 (1.56–12.67) | 0.005 |
| In-hospital MACE | 5.92 (2.75–12.77) | <0.001 | 1.05 (1.002–1.11) | 0.038 | 2.22 (1.19–4.15) | 0.013 |
| Follow-up mortality | 4.69 (1.93–11.42) | 0.001 | 1.07 (1.04–1.10) | <0.001 | 2.88 (1.53–5.43) | 0.001 |
APRI, Aspartate transaminase to platelet ratio index; MELD, model of end-stage liver disease; ALBI, albumin-bilirubin; MACE, major adverse clinical events.
*Details in the Supplementary Tables 2–4.